NERVGEN PHARMA CORP. Increase Decrease Through Share-based Payment Transactions
NERVGEN PHARMA CORP. (NGEN) reported Increase Decrease Through Share-based Payment Transactions of CAD 5.39 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2026-03-31
| Period end | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|
| 2025-12-31 | 5.39M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 6.04M CAD 40-F · filed 2026-03-31 |